Related Experiment Video
Updated: Aug 18, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
[Amiodarone causes endothelium-dependent vasodilation in canine coronary arteries]
Alfredo José Rodrigues1, Paulo Roberto Barbosa Evora, Ayako Maruo
1Faculdade de Medicina de Ribeirão Preto, USP, Ribeirão Preto, SP. alfredo@smnp.usp.br
Insights
Amiodarone causes vasodilation in canine coronary arteries by stimulating nitric oxide and cyclooxygenase-dependent factors. This effect is endothelium-dependent and more pronounced with polysorbate 80 or commercial formulations.
Area of Science:
- Pharmacology
- Cardiovascular Physiology
Context:
- Amiodarone is an antiarrhythmic drug with potential vasodilatory effects.
- Understanding amiodarone's impact on coronary arteries is crucial for cardiovascular health.
- Canine coronary arteries serve as a model for studying vascular responses.
Purpose:
- To investigate the vasodilating effects of amiodarone on canine coronary arteries.
- To compare the efficacy of amiodarone dissolved in polysorbate 80 versus water.
- To elucidate the mechanisms underlying amiodarone-induced vasodilation.
Summary:
- Amiodarone, particularly when dissolved in polysorbate 80 or as a commercial formulation (Cordarone), induced endothelium-dependent vasodilation in canine coronary arteries.
- Polysorbate 80 alone caused minimal non-endothelium-dependent relaxation.
- The vasodilation was primarily mediated by nitric oxide and cyclooxygenase-dependent pathways, as evidenced by the blockade of these effects with indomethacin and N-omega-nitro-L-arginine.
Impact:
- Reveals amiodarone's vasodilatory properties in coronary circulation.
- Highlights the role of the endothelium and specific signaling pathways in amiodarone's vascular effects.
- Provides insights into formulation-dependent differences in amiodarone's pharmacological actions.
Objective:
To assess the vasodilating effects of amiodarone on canine coronary arteries by using solutions of amiodarone dissolved in polysorbate 80 or water.
Methods:
Rings of coronary arteries, with or without intact endothelium, were immersed in Krebs solution and connected to a transducer for measuring the isometric force promoted by a vascular contraction. The arteries were exposed to increasing concentrations of polysorbate 80, amiodarone dissolved in water, amiodarone dissolved in polysorbate 80, and a commercial presentation of amiodarone (Cordarone). The experiments were conducted in the presence of the following enzymatic blockers: only indomethacin, Nomega-nitro-L-arginine associated with indomethacin, and only Nomega-nitro-L-arginine.
Results:
Polysorbate 80 caused a small degree of nonendothelium-dependent relaxation. Cordarone, amiodarone dissolved in water, and amiodarone dissolved in polysorbate 80 caused endothelium-dependent relaxation, which was greater for amiodarone dissolved in polysorbate and for Cordarone. Only the association of indomethacin and Nomega-nitro-L-arginine could eliminate the endothelium-dependent relaxation caused by amiodarone dissolved in polysorbate 80.
Conclusion:
The results obtained indicate that vasodilation promoted by amiodarone in canine coronary arteries is mainly caused by stimulation of the release of nitric oxide and cyclooxygenase-dependent relaxing endothelial factors.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Coronary Artery Disease II: Pathophysiology
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antihypertensive Drugs: Action of Calcium Channel Blockers

